FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

George Aggrey

Research Profile

Chemicals & Drugs

Concepts & Ideas

Procedures

Devices

Stents

Disorders

Geographic Areas

District of Columbia

Co-author Network

Publications

TOP 3
William W Chu; Pramod K Kuchulakanti; Seung-Woon Rha; Afework GebreEyesus; George Aggrey; Rebecca Torguson; Betty Wang; Zhenyi Xue; Leonardo C Clavijo; William O Suddath; Augusto D Pichard; Lowell F Satler; Kenneth M Kent; Ron Waksman
Impact of three or more versus a single sirolimus-eluting stent on outcomes in patients who undergo percutaneous coronary intervention.
Seung-Woon Rha; Pramod K Kuchulakanti; Rajbabu Pakala; edouard cheneau; Jana Fournadjiev; Ellen Pinnow; Afework GebreEyesus; George Aggrey; Zuyue Wang; Augusto D Pichard; Lowell F Satler; Kenneth M Kent; Joseph Lindsay; Ron Waksman
Bivalirudin versus heparin as an antithrombotic agent in patients treated with a sirolimus-eluting stent.
Joseph Lindsay; Daniel Canos; Sue Apple; Ellen Pinnow; George Aggrey; Augusto D Pichard
Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatine kinase-MB versus rise of serum creatinine.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of George Aggrey (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: William W Chu; Pramod K Kuchulakanti; Seung-Woon Rha; Afework GebreEyesus; George Aggrey; Rebecca Torguson; Betty Wang; Zhenyi Xue; Leonardo C Clavijo; William O Suddath; Augusto D Pichard; Lowell F Satler; Kenneth M Kent; Ron Waksman
Impact of three or more versus a single sirolimus-eluting stent on outcomes in patients who undergo percutaneous coronary intervention.
The American journal of cardiology 2006;97(5):606-10.
2004: Seung-Woon Rha; Pramod K Kuchulakanti; Rajbabu Pakala; edouard cheneau; Jana Fournadjiev; Ellen Pinnow; Afework GebreEyesus; George Aggrey; Zuyue Wang; Augusto D Pichard; Lowell F Satler; Kenneth M Kent; Joseph Lindsay; Ron Waksman
Bivalirudin versus heparin as an antithrombotic agent in patients treated with a sirolimus-eluting stent.
The American journal of cardiology 2004;94(8):1047-50.
2004: Joseph Lindsay; Daniel Canos; Sue Apple; Ellen Pinnow; George Aggrey; Augusto D Pichard
Causes of acute renal dysfunction after percutaneous coronary intervention and comparison of late mortality rates with postprocedure rise of creatine kinase-MB versus rise of serum creatinine.
The American journal of cardiology 2004;94(6):786-9.
2004: Seung-Woon Rha; Pramod K Kuchulakanti; Rajbabu Pakala; edouard cheneau; Ellen Pinnow; Afework GebreEyesus; George Aggrey; Augusto D Pichard; Lowell F Satler; Kenneth M Kent; Joseph Lindsay; Ron Waksman
Addition of heparin to contrast media is associated with increased bleeding and peripheral vascular complications during percutaneous coronary intervention with bivalirudin and drug-eluting stents.
Cardiovascular radiation medicine 2004;5(2):64-70.